BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34292498)

  • 1. Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management.
    Jalal M; Campbell JA; Wadsley J; Hopper AD
    J Gastrointest Cancer; 2021 Sep; 52(3):1183-1187. PubMed ID: 34292498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
    Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
    Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
    Özkul B; Özkul Ö; Bilir C
    Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
    Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
    Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
    PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
    Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
    Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy.
    Cho WK; Yu JI; Park HC; Lim DH; Kim TH; Chie EK
    Tumori; 2021 Jun; 107(3):247-253. PubMed ID: 32646298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
    Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
    Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer.
    Salinas-Miranda E; Deniffel D; Dong X; Healy GM; Khalvati F; O'Kane GM; Knox J; Bathe OF; Baracos VE; Gallinger S; Haider MA
    Eur Radiol; 2021 Nov; 31(11):8662-8670. PubMed ID: 33934171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and CT defined sarcopenia in patients with intestinal failure on home parenteral support.
    Oke SM; Rye B; Malietzis G; Baldwin-Cleland R; Bottle A; Gabe SM; Lung PFC
    Clin Nutr; 2020 Mar; 39(3):829-836. PubMed ID: 30962104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
    Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
    Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
    Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
    Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer.
    ; Mari A; D'Andrea D; Kimura S; Resch I; Shariat SF; Klatte T
    Urol Int; 2018; 101(2):197-200. PubMed ID: 30089304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of pre-sarcopenia from a single selectional crosscut at C3 region, using CT scans before radiotherapy.
    Muresan BT; Sánchez Juan C; Artero A; Hernández Machancoses A; Almendros-Blanco P; Montoro A; Sánchez Jordá G; Marco-Alacid C; Ríos Ríos J; Soriano Del Castillo JM; Sánchez Guillén L; López-Torrecilla J
    Nutr Hosp; 2019 Oct; 36(5):1101-1108. PubMed ID: 31475837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.